Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 28, 2019
WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failureMichael E Seifert, Joseph P Gaut, Boyi Guo, et al.
Oncotarget|April 21, 2017
Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targetsEddy S Yang, Christopher D Willey, Amitkumar Mehta, et al.
Oncology Letters|April 30, 2017
MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell linesTimothy D Rohrbach, Robert B Jones, Patricia H Hicks, et al.
Frontiers in Genetics|November 2, 2020
Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma GrowthLing Zeng, Drexell Hunter Boggs, Chuan Xing, et al.
Plos One|February 19, 2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, et al.
Cancer Letters|May 27, 2024
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumorZeta Chow, Jeremy Johnson, Aman Chauhan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2014
Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolinesJoshua C Anderson, Christine W Duarte, Karim Welaya, et al.
Physics in Medicine and Biology|May 21, 2013
Segmentation editing improves efficiency while reducing inter-expert variation and maintaining accuracy for normal brain tissues in the presence of space-occupying lesionsM A Deeley, A Chen, R D Datteri, et al.
Molecular Cancer Therapeutics|March 30, 2018
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) InhibitionMonica E Wielgos, Zhuo Zhang, Rajani Rajbhandari, et al.
Breast Cancer Research and Treatment|February 3, 2023
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancerChristos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, et al.
Pageof 13